These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

209 related articles for article (PubMed ID: 23470615)

  • 1. Effect of follicle-stimulating hormone receptor N680S polymorphism on the efficacy of follicle-stimulating hormone stimulation on donor ovarian response.
    Lledo B; Guerrero J; Turienzo A; Ortiz JA; Morales R; Ten J; Llacer J; Bernabeu R
    Pharmacogenet Genomics; 2013 May; 23(5):262-8. PubMed ID: 23470615
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical efficacy of recombinant versus highly purified follicle-stimulating hormone according to follicle-stimulating hormone receptor genotype.
    Lledó B; Dapena P; Ortiz JA; Morales R; Llacer J; Bernabeu R
    Pharmacogenet Genomics; 2016 Jun; 26(6):288-93. PubMed ID: 26959715
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Ser680Asn polymorphism in the follicle-stimulating hormone receptor gene is associated with the ovarian response in controlled ovarian hyperstimulation.
    Huang X; Li L; Hong L; Zhou W; Shi H; Zhang H; Zhang Z; Sun X; Du J
    Clin Endocrinol (Oxf); 2015 Apr; 82(4):577-83. PubMed ID: 25132286
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Intermediate and normal sized CGG repeat on the FMR1 gene does not negatively affect donor ovarian response.
    Lledo B; Guerrero J; Ortiz JA; Morales R; Ten J; Llacer J; Gimenez J; Bernabeu R
    Hum Reprod; 2012 Feb; 27(2):609-14. PubMed ID: 22157911
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Triggering with human chorionic gonadotropin or a gonadotropin-releasing hormone agonist in gonadotropin-releasing hormone antagonist-treated oocyte donor cycles: findings of a large retrospective cohort study.
    Bodri D; Guillén JJ; Galindo A; Mataró D; Pujol A; Coll O
    Fertil Steril; 2009 Feb; 91(2):365-71. PubMed ID: 18367175
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The N680S variant in the follicle-stimulating hormone receptor gene identifies hyperresponders to controlled ovarian stimulation.
    Nenonen HA; Lindgren IA; Prahl AS; Trzybulska D; Kharraziha I; Hultén M; Giwercman YL; Henic E
    Pharmacogenet Genomics; 2019 Jul; 29(5):114-120. PubMed ID: 30829738
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of follicle-stimulating hormone receptor Asn680Ser polymorphism on the outcomes of controlled ovarian hyperstimulation: an updated meta-analysis of 16 cohort studies.
    Tang H; Yan Y; Wang T; Zhang T; Shi W; Fan R; Yao Y; Zhai S
    J Assist Reprod Genet; 2015 Dec; 32(12):1801-10. PubMed ID: 26481502
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Influence of FSHR diplotypes on ovarian response to standard gonadotropin stimulation for IVF/ICSI.
    Lazaros L; Hatzi E; Xita N; Takenaka A; Sofikitis N; Zikopoulos K; Georgiou I
    J Reprod Med; 2013; 58(9-10):395-401. PubMed ID: 24050028
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison between a GnRH antagonist and a GnRH agonist flare-up protocol in oocyte donors: a randomized clinical trial.
    Bodri D; Vernaeve V; Guillén JJ; Vidal R; Figueras F; Coll O
    Hum Reprod; 2006 Sep; 21(9):2246-51. PubMed ID: 16704995
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Comparison of GnRH agonists and antagonists in an ovular donation program].
    Saucedo de la Llata E; Moraga Sánchez MR; Batiza Reséndiz V; Santos Haliscak R; Galache Vega P; Hernández Ayup S
    Ginecol Obstet Mex; 2004 Feb; 72():53-6. PubMed ID: 15216901
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluating influence of the genotypes in the follicle-stimulating hormone receptor (FSHR) Ser680Asn (rs6166) polymorphism on poor and hyper-responders to ovarian stimulation: a meta-analysis.
    Pabalan N; Trevisan CM; Peluso C; Jarjanazi H; Christofolini DM; Barbosa CP; Bianco B
    J Ovarian Res; 2014 Dec; 7():285. PubMed ID: 25526787
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Triggering ovulation with gonadotropin-releasing hormone agonist in in vitro fertilization patients with polycystic ovaries does not cause ovarian hyperstimulation syndrome despite very high estradiol levels.
    Manzanares MA; Gómez-Palomares JL; Ricciarelli E; Hernández ER
    Fertil Steril; 2010 Mar; 93(4):1215-9. PubMed ID: 19200978
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The influence of estradiol/follicle and estradiol/oocyte ratios on the outcome of controlled ovarian stimulation for in vitro fertilization.
    Orvieto R; Zohav E; Scharf S; Rabinson J; Meltcer S; Anteby EY; Homburg R
    Gynecol Endocrinol; 2007 Feb; 23(2):72-5. PubMed ID: 17454155
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Comparison of GnRH antagonist fixed protocol and GnRH agonists long protocol in infertile patients with normal ovarian reserve function in their first in vitro fertilization-embryo transfer cycle].
    Yang S; Chen XN; Qiao J; Liu P; Li R; Chen GA; Ma CH
    Zhonghua Fu Chan Ke Za Zhi; 2012 Apr; 47(4):245-9. PubMed ID: 22781108
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Could polymorphisms of some hormonal receptor genes, involved in folliculogenesis help in predicting patient response to controlled ovarian stimulation?
    Čuš M; Vlaisavljević V; Repnik K; Potočnik U; Kovačič B
    J Assist Reprod Genet; 2019 Jan; 36(1):47-55. PubMed ID: 30406448
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Short coasting of 1 or 2 days by withholding both gonadotropins and gonadotropin-releasing hormone agonist prevents ovarian hyperstimulation syndrome without compromising the outcome.
    Moon HS; Joo BS; Moon SE; Lee SK; Kim KS; Koo JS
    Fertil Steril; 2008 Dec; 90(6):2172-8. PubMed ID: 18439601
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Follicle-stimulating hormone receptor gene polymorphism and ovarian responses to controlled ovarian hyperstimulation for IVF-ET.
    Jun JK; Yoon JS; Ku SY; Choi YM; Hwang KR; Park SY; Lee GH; Lee WD; Kim SH; Kim JG; Moon SY
    J Hum Genet; 2006; 51(8):665-670. PubMed ID: 16871362
    [TBL] [Abstract][Full Text] [Related]  

  • 18. FSH receptor genotype and its influence on the results of donor ovarian stimulation using corifollitropin alfa.
    Lledó B; Ortiz JA; Hortal M; Cascales A; Morales R; Guerrero J; Bernabeu A; Bernabeu R
    Reprod Biomed Online; 2022 Nov; 45(5):943-946. PubMed ID: 36075849
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Poor ovarian response to gonadotropin stimulation is associated with low expression of follicle-stimulating hormone receptor in granulosa cells.
    Cai J; Lou HY; Dong MY; Lu XE; Zhu YM; Gao HJ; Huang HF
    Fertil Steril; 2007 Jun; 87(6):1350-6. PubMed ID: 17296182
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Clinical application of gonadotropin-releasing hormone antagonist in Chinese women undergoing controlled ovarian hyperstimulation for in vitro fertilization and embryo transfer].
    Chen SL; Yin MN; Sun L; Li H; Chen X; Song HD; He JX; Zhu L; Xing FQ
    Nan Fang Yi Ke Da Xue Xue Bao; 2007 May; 27(5):588-90. PubMed ID: 17545062
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.